Cargando…

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort

Mostrar otras versiones (1)

OBJECTIVE: Damage in patients with systemic lupus erythematosus is irreversible change in organs due to disease activity, concomitant disease or medication side-effects. It is measured using the Systemic Lupus International Collaborative Clinics Damage Index (SDI) and is associated with increased mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Segura, Beatriz Tejera, Bernstein, Brett Sydney, McDonnell, Thomas, Wincup, Chris, M Ripoll, Vera, Giles, Ian, Isenberg, David, Rahman, Anisur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414923/ https://www.ncbi.nlm.nih.gov/pubmed/31377781 http://dx.doi.org/10.1093/rheumatology/kez292

Ejemplares similares

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
por: Segura, Beatriz Tejera, et al.
Publicado: (2019)

Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus
por: Bakshi, Jyoti, et al.
Publicado: (2017)

Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort
por: Tejera Segura, Beatriz, et al.
Publicado: (2019)

Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?
por: Pericleous, Charis, et al.
Publicado: (2020)

Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events
por: Farina, Nicola, et al.
Publicado: (2022)

Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I
por: McDonnell, Thomas, et al.
Publicado: (2018)

Going viral in rheumatology: using social media to show that mechanistic research is relevant to patients with lupus and antiphospholipid syndrome
por: McDonnell, Thomas C R, et al.
Publicado: (2018)

Menorrhagia: an underappreciated problem in pre-menopausal women with systemic lupus erythematosus
por: Wincup, C, et al.
Publicado: (2019)

Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus
por: Wincup, Chris, et al.
Publicado: (2021)

The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS
por: McDonnell, Thomas, et al.
Publicado: (2020)

Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome
por: Artim-Esen, Bahar, et al.
Publicado: (2017)

British isles lupus assessment group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus
por: Yee, Chee-Seng, et al.
Publicado: (2007)

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
por: Bruce, Ian N, et al.
Publicado: (2015)

Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus
por: Raymond, Warren, et al.
Publicado: (2018)

Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up
por: Luo, Weike, et al.
Publicado: (2022)

Prognostic Factors at Diagnosis Associated With Damage Accrual in Childhood-Onset Systemic Lupus Erythematosus Patients
por: Rodríguez-Lozano, Ana Luisa, et al.
Publicado: (2022)

Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus
por: Wincup, Chris, et al.
Publicado: (2019)

Systemic lupus erythematosus
por: Manson, Jessica J, et al.
Publicado: (2006)

High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus
por: Koelmeyer, Rachel, et al.
Publicado: (2020)

Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort study
por: Croca, Sara, et al.
Publicado: (2014)

Lupus and the Lungs: The Assessment and Management of Pulmonary Manifestations of Systemic Lupus Erythematosus
por: Amarnani, Raj, et al.
Publicado: (2021)

High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus
por: Reid, Sarah, et al.
Publicado: (2020)

The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus
por: Robinson, George Anthony, et al.
Publicado: (2022)

Cytokines in systemic lupus erythematosus, London, UK
por: Rahman, Anisur
Publicado: (2003)

Outcomes of membranous and proliferative lupus nephritis – analysis of a single-centre cohort with more than 30 years of follow-up
por: Farinha, Filipa, et al.
Publicado: (2020)

Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus
por: Bakshi, Jyoti, et al.
Publicado: (2022)

Belimumab in systemic lupus erythematosus
por: Vilas-Boas, Andreia, et al.
Publicado: (2015)

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
por: McCarthy, Eoghan M, et al.
Publicado: (2018)

Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2023)

Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome
por: Ripoll, Vera M., et al.
Publicado: (2018)

IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study
por: Croca, Sara, et al.
Publicado: (2015)

Imaging Assessment of Cardiovascular Disease in Systemic Lupus Erythematosus
por: Croca, Sara C., et al.
Publicado: (2012)

Towards Precision Medicine in Systemic Lupus Erythematosus
por: Lever, Elliott, et al.
Publicado: (2020)

Systemic Lupus Erythematosus: Genomics, Mechanisms, and Therapies
por: Fernández-Nebro, Antonio, et al.
Publicado: (2012)

Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus
por: Piga, Matteo, et al.
Publicado: (2017)

The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts
por: Frodlund, M, et al.
Publicado: (2019)

LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
por: Ugarte-Gil, Manuel Francisco, et al.
Publicado: (2022)

Profile of atacicept and its potential in the treatment of systemic lupus erythematosus
por: Cogollo, Estafania, et al.
Publicado: (2015)

Antiphospholipid antibodies enhance rat neonatal cardiomyocyte apoptosis in an in vitro hypoxia/reoxygenation injury model via p38 MAPK
por: Bourke, Lauren T, et al.
Publicado: (2017)

Tumid Lupus Erythematosus Presenting as Patchy Alopecia: A Discussion of Alopecia Associated With Lupus Erythematosus
por: Henehan, Mason R, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ler1jppr18kaf4o2jese10la3i